Odin Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
300 Franklin Square Dr, Somerset, New Je...Phone Number
(732) 554-1100Website
www.odinpharmaceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Odin Pharmaceuticals
Odin Pharmaceuticals is a sterile pharmaceutical company that develops and markets injectable and ophthalmic drugs for the US healthcare market. Founded in 2018 by Dr. Veerappan Subramanian and Dr. Ilango Subramanian, the company boasts a robust pipeline of products. Their focus is primarily on providing high-quality generics and innovative solutions in sterile drug delivery. Odin Pharmaceuticals aims to serve healthcare providers and patients seeking reliable pharmaceutical options.Explore more
Odin Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Odin Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Odin Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Odin Pharmaceuticals has new funding data
Odin Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Odin Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Odin Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Odin Pharmaceuticals had a recent Job posting/layoffs
Check if Odin Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Odin Pharmaceuticals is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Odin Pharmaceuticals
Compare insights from companies similar to Odin Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Odin Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Odin Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Odin Pharmaceuticals.
Odin Pharmaceuticals Tech Stack
A closer look at the technologies used by Odin Pharmaceuticals
Most Recent Scoops
New Hire
Executive Move
Mark Mendenhall has joined the organization as Vice President, Institutional Sales.
Executive Moves, New Hire
Left Company
Executive Move
Kevin Congdon, Senior Director, Institutional Sales, has left the organization and now serves as the Marketing Vice President, Institutional Sales at Accord Healthcare.
Funding
Odin Pharmaceuticals has received an SBA PPP loan for $350,000-1 million from Bank of America, supporting the retention of 27 jobs.
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Odin Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Odin Pharmaceuticals is a sterile pharmaceutical company that develops and markets injectable and ophthalmic drugs for the US healthcare market. Founded in 2018 by Dr. Veerappan Subramanian and Dr. Ilango Subramanian, the company boasts a robust pipeline of products. Their focus is primarily on providing high-quality generics and innovative solutio... Read More
